Literature DB >> 34925613

Clear Cell Hidradenocarcinoma: a Rare Identity Difficult to Recognize - Case Report and Review of the Literature.

Danilo Coco1, Silvana Leanza2, Roberto Campagnacci2.   

Abstract

Hidradenocarcinoma (HC) is a malignant and aggressive sweat gland tumour. It is a rare occurrence, accounting for about 6% of malignant eccrine cancers and less than 1% of all cutaneous neoplasms. It is a malignant tumor which can manifest itself in any area of the body, including the anterior surface of the trunk, the torso, scalp, face, and extremities. It is apparent that HC has a high propensity for lymphatic metastasis. The suggested treatment approach for HC implies making a wide surgical excision with negative margins. Nevertheless, such tumours are aggressive and recur locally in 50% of cases; they also produce metastases in 60% of cases. The overall five-year survival rate is 30%. Here, we present the case of a 68-year-old Caucasian male with unknown diagnosis of malignant neoplasm of inguinal cutaneous skin of sweat gland called hydrocarcinoma.

Entities:  

Year:  2021        PMID: 34925613      PMCID: PMC8643562          DOI: 10.26574/maedica.2020.16.3.526

Source DB:  PubMed          Journal:  Maedica (Bucur)        ISSN: 1841-9038


  19 in total

Review 1.  Hidradenomas and a hidradenocarcinoma of the scalp managed using Mohs micrographic surgery and a multidisciplinary approach: case reports and review of the literature.

Authors:  Regina Yavel; Molly Hinshaw; Venkat Rao; Gregory K Hartig; Paul M Harari; Daniel Stewart; Stephen N Snow
Journal:  Dermatol Surg       Date:  2009-02       Impact factor: 3.398

Review 2.  Hidradenocarcinomas: a brief review and future directions.

Authors:  Steven Gauerke; James J Driscoll
Journal:  Arch Pathol Lab Med       Date:  2010-05       Impact factor: 5.534

3.  Malignant hidradenoma: a report of two cases and review of the literature.

Authors:  I E Liapakis; D P Korkolis; A Koutsoumbi; A Fida; G Kokkalis; P P Vassilopoulos
Journal:  Anticancer Res       Date:  2006 May-Jun       Impact factor: 2.480

4.  [Hidradenocarcinoma of the heel associated with inguinal metastases].

Authors:  W Labbardi; F Hali; F Marnissi; B Cribier; S Chiheb
Journal:  Ann Dermatol Venereol       Date:  2017-05-18       Impact factor: 0.777

5.  Metastatic hidradenocarcinoma: Surgery and chemotherapy.

Authors:  Trabelsi Amel; Gharbi Olfa; Hammedi Faten; Hochlef Makrem; Ben Ahmed Slim; Mokni Moncef
Journal:  N Am J Med Sci       Date:  2009-12

Review 6.  Current management approach to hidradenocarcinoma: a comprehensive review of the literature.

Authors:  Abhishek Soni; Nupur Bansal; Vivek Kaushal; Ashok Kr Chauhan
Journal:  Ecancermedicalscience       Date:  2015-03-19

7.  Complete response in a patient with gynecological hidradenocarcinoma treated with exclusive external beam radiotherapy and brachytherapy: a case report.

Authors:  Flavio Giannelli; Ilaria Chiola; Liliana Belgioia; Stefania Garelli; Alice Pastorino; Michela Marcenaro; Serafina Mammoliti; Sergio Costantini; Nicolò Bizzarri; Valerio Vellone; Salvina Barra; Renzo Corvò
Journal:  J Contemp Brachytherapy       Date:  2017-12-30

8.  Hidradenocarcinoma: Five Years of Local and Systemic Control of a Rare Sweat Gland Neoplasm with Nodal Metastasis.

Authors:  Benazir Mir Khan; Muhammad Atif Mansha; Nasir Ali; Ahmed Nadeem N Abbasi; Syed Mustajab Ahmed; Bilal M Qureshi
Journal:  Cureus       Date:  2018-06-26

9.  An Unusual Case of Lower Extremity Clear Cell Hidradenocarcinoma.

Authors:  Marc Rafols; Odille Mejia; Kei Shing Oh; Blake Bendixen; Irving Jorge; Sumana Narayanan
Journal:  Case Rep Surg       Date:  2020-04-08

10.  Clear cell hidradenoma of breast mimicking atypical breast lesion: a diagnostic pitfall in breast cytology.

Authors:  Shelly Sehgal; Prashant Goyal; Soumyesh Ghosh; Deepti Mittal; Awanindra Kumar; Sompal Singh
Journal:  Rare Tumors       Date:  2014-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.